A clinical trial conducted in the midst of an Ebola epidemic in the Democratic Republic of Congo (DRC) has identified two new drugs that can dramatically cut mortality from the disease, and both are being immediately offered to all patients in an effort to control the country’s worst ever outbreak.
The Pamoja Tulinde Maisha (“together save lives” in Swahili) trial began last November, in four towns stricken by the outbreak. It compared four potential treatments proposed by four different companies: ZMapp, remdesivir, mAb114, and REGN-EB3.
Preliminary data has convinced the trial’s monitoring board to stop the study and randomise all remaining patients to either mAb114 or REGN-EB3.1
Data from the first 499 patients showed that REGN-EB3 had met early stopping criteria, and mAb114 was not far behind. Among all patients who took the drugs, those treated with REGN-EB3 had a mortality rate of 29%, while those who got mAb-114 had a mortality rate of 34%.
Patients treated with ZMapp, the best known Ebola treatment candidate, which was used in the west African epidemic of 2014, had a 49% mortality rate. Those treated with the antiviral remdesivir had a 53% mortality rate.
More than 75% of those who received no treatment have died in the epidemic, which has killed nearly 1900 people out of 2831 confirmed cases.
Researchers believe they can improve outcomes further in patients who are reached early in the course of infection. Among such patients, mortality rates were 6% with REGN-EB3, 11% with mAb114, 24% with ZMapp, and 33% with remdesivir.
Both REGN-EB3 and mAb114, like ZMapp, are monoclonal antibodies, proteins that bind to other proteins on the outer shell of the Ebola virus, which it uses to attach itself to human cells.
Regeneron Pharmaceuticals made REGN-EB3, a cocktail of three such proteins, using antibodies from “humanised” mice infected with Ebola.
The US National Institute of Allergy and Infectious Diseases created mAb114 using antibodies isolated from the blood of a survivor of a 1995 outbreak in DRC. It will be developed by Ridgeback Therapeutics.
“From now on, we will no longer say that Ebola is incurable,” said Jean-Jacques Muyembe-Tamfum, director of the DRC’s Institut National de Recherche Biomédicale, which oversaw the trial. Full results are expected by early October and will appear in a peer reviewed journal soon thereafter.
Muyembe, who was part of the team that discovered the Ebola virus 43 years ago, and who in 1995 became the first doctor to harvest antibodies from survivors, told a press conference that the news of effective treatments would reinvigorate the campaign to end the current outbreak, which has struggled against deep local suspicion in a region plagued by insecurity.
“People think that if you enter a treatment centre, you’ll leave in a coffin,” said Muyembe. But with such high survival rates in the newly infected, he said, “We have a great message: a treatment centre is a place where you can recover and that you leave alive.”
Learn more: Two Ebola treatments halve deaths in trial in DRC outbreak
The Latest on: Ebola
[google_news title=”” keyword=”Ebola” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Ebola
- Ebola's exponential growthon May 16, 2024 at 5:00 pm
The U.S. government’s Centers for Disease Control warned recently that we could have 1.4 million cases of Ebola by January. By Gwynne Dyer - Here are two good things about the Ebola virus. It is ...
- Lassa fever case in Paris: What you need to knowon May 13, 2024 at 11:00 am
A case of Lassa fever has been reported in Paris, France, sparking lurid warnings about the "horrific Ebola-like bug".
- Newsday - How I survived Ebola but it changed my life forever - BBC Soundson May 13, 2024 at 10:01 am
Preston Gorman on how he dealt with PTSD after recovering from the virus ...
- Ebola Outbreak in West Africa, 2013-2014on May 12, 2024 at 5:00 pm
The Ebola virus disease outbreak now ravaging parts of West Africa is the largest on record. In fact, West Africa has seen more cases of the disease in 2014 than have been seen in all other ...
- Lassa fever: Ebola-like bug that causes bleeding from the eyes and spread by rats found in Parison May 12, 2024 at 1:05 am
A new case of the Ebola-like Lassa virus, which causes many of the same symptoms including bleeding from the nose and eyes, has been detected in a patient in Paris, France ...
- Newsday - 'We've been handling Ebola as an emergency for a year' - DR Congo minister - BBC Soundson May 8, 2024 at 12:10 am
Democratic Republic of Congo outbreak declared public health emergency by WHO ...
- Chinese scientists create mutant Ebola virus that killed hamsters to 'avoid biosafety rules'on May 7, 2024 at 2:10 pm
Scientists in China created a mutant Ebola virus in a lab that killed hamsters to "avoid biosafety rules". Researchers at Hebei Medical University combined a contagious livestock disease and a protein ...
- Horrific Ebola-like bug that causes bleeding from the eyes detected in Paris after ‘worst outbreak on record’on May 7, 2024 at 8:01 am
A CASE of Lassa fever has been reported in the Paris region. The patient, a soldier who had recently returned from abroad, is now being treated at the Bégin military hospital in Saint-Mandé, ...
- Chinese scientists create new mutant Ebola strain with horror eye symptomson May 7, 2024 at 5:35 am
Researchers at Hebei Medical University in China have used a protein that is found in Ebola alongside a contagious disease in hamsters that wiped out the rodents ...
- Chinese scientists create mutant Ebola virus in labon May 5, 2024 at 5:00 pm
While the experiment may spark fears of another lab leak, the researchers say their goal was to find the right animal models that can safely mimic Ebola symptoms in a lab setting. The study suggested ...
via Bing News